<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-87137</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Reply: Relationship of serum type I collagen telopeptide carboxy terminal with bone mineral density and drug consumption in postmenopausal women. Preliminary data from the FRODOS study</dc:title>
<dc:description xml:lang="en">No disponible</dc:description>
<dc:creator>Kanterewicz, Eduard</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Med. clín (Ed. impr.);136(6): 270-270, mar. 2011.</dc:source>
<dc:identifier>ibc-87137</dc:identifier>
<dc:title xml:lang="es">Respuesta: Relación del telopéptido carboxiterminal del colágeno tipo i sérico con la densidad mineral ósea y el consumo de fármacos en mujeres posmenopáusicas. Datos preliminares del estudio FRODOS</dc:title>
<dc:subject>^d36240^s22062</dc:subject>
<dc:subject>^d29625</dc:subject>
<dc:subject>^d24543^s22031</dc:subject>
<dc:subject>^d29638</dc:subject>
<dc:subject>^d24823^s22032</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d2309^s22002</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:type>article</dc:type>
<dc:date>201103</dc:date>
</metadata>
</record>
</ibecs-document>
